Association between piperacillin/tazobactam MIC and survival among hospitalized patients with Enterobacterales infections: retrospective cohort analysis of electronic health records from 161 US hospitals.

Jeffrey R StrichAlexander LawandiSarah WarnerCumhur Y DemirkaleSadia SarzynskiAhmed BabikerJohn P DekkerSameer S Kadri

Published in: JAC-antimicrobial resistance (2023)

Clinical data suggest improved outcomes when piperacillin/tazobactam is prescribed for Enterobacterales infections with an MIC of ≤16/4 mg/L compared with ≥32/4 mg/L.

Keyphrases

electronic health record
clinical decision support
adverse drug
gram negative
healthcare
cross sectional
big data
free survival
machine learning
artificial intelligence
skeletal muscle
insulin resistance
weight loss
glycemic control
data analysis